SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer

NCT03603756 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: SHR-1210
DRUG: Apatinib
DRUG: Irinotecan Injection
DRUG: Paclitaxel liposome
DRUG: Nedaplatin

Sponsor

Chinese Academy of Medical Sciences